Idarubicin Hydrochloride

Idarubicin Hydrochloride

57852-57-0

C26H27NO9 ·HCl

idarubicin hydrochloride, Idarubicin Hcl, 57852-57-0, Idamycin, Zavedos, Idarubicin (hydrochloride), 4-Demethoxydaunorubicin, IMI 30, IMI-30, 5VV3MDU5IE, 4-Demethoxydaunorubicin hydrochloride, Idarubicinhydrochloride, CPD000466355, DTXSID0047797, MLS001401448, NSC-256439, SMR000466355, DTXCID0027775, Idamycin PFS, (7S,9S)-9-acetyl-7-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,9,11-trihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride, CAS-57852-57-0, NSC 256439, NCGC00093976-03, UNII-5VV3MDU5IE, Idarubicin hydrochloride PFS, SR-01000075934, Idamycin (TN), EINECS 260-990-7, Idarubicin hydrochlorid, Idarubicin hydrochloride [USAN:USP:INN], SCHEMBL4838, MLS000759470, CHEMBL1200976, CHEBI:31686, KUC110342C, EX-A1148, Tox21_111236, IDARUBICIN HYDROCHLORIDE [MI], MFCD00897212, s1228, Idarubicin hydrochloride (JP17/USP), IDARUBICIN HYDROCHLORIDE [JAN], AKOS025402118, Tox21_111236_1, AC-5255, CCG-100886, CS-1061, IDARUBICIN HYDROCHLORIDE [USAN], NC00136, Daunomycin, 4-demethoxy-, hydrochloride, IDARUBICIN HYDROCHLORIDE [MART.], IDARUBICIN HYDROCHLORIDE [VANDF], IDARUBICIN HYDROCHLORIDE [USP-RS], IDARUBICIN HYDROCHLORIDE [WHO-DD], NCGC00093976-08, (1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside, hydrochloride, AS-75944, HY-17381, KSC-230-185-1, IDARUBICIN HYDROCHLORIDE [ORANGE BOOK], D01747, IDARUBICIN HYDROCHLORIDE [USP MONOGRAPH], Q-101407, SR-01000075934-5, 4-demethoxydaunorubicin (NSC256439, 4-DMDR) HCl, Q27262943, (7S,9S)-9-acetyl-7-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,9,11-trihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dionehydrochloride, (7S,9S)-9-acetyl-7-((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-6,9,11-trihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride,

533.95

Typically NLT 98%